- Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapyAudrey Y Chu
Center for Cardiovascular Disease Prevention, the Division of Preventive Medicine, Brigham and Women s Hospital, Boston, MA, USA
Circ Cardiovasc Genet 5:676-85. 2012..Data are sparse regarding genetic determinants of Lp-PLA(2) mass and activity, and no prior data are available addressing genetic determinants of statin-induced changes for this proinflammatory biomarker...
- Pharmacogenetic determinants of statin-induced reductions in C-reactive proteinAudrey Y Chu
Center for Cardiovascular Disease Prevention, Division of Preventive Medicine, Brigham and Women s Hospital, 900 Commonwealth Ave E, Boston, MA 02215, USA
Circ Cardiovasc Genet 5:58-65. 2012..However, whether different mechanisms underlie statin-induced CRP and LDL-C reduction is unknown...
- Sugar-sweetened beverages and genetic risk of obesityQibin Qi
Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA
N Engl J Med 367:1387-96. 2012..Temporal increases in the consumption of sugar-sweetened beverages have paralleled the rise in obesity prevalence, but whether the intake of such beverages interacts with the genetic predisposition to adiposity is unknown...